AB | BC | MB | NB | NL | NS | NT | ON | PE | QC | SK | YT

News & Announcements

2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

June | May | Apr | Mar | Feb | Jan

Health Product Risk Communication
June 06, 2016

ATARAX (hydroxyzine) - Risk of QT Prolongation and Torsade de Pointes - Erfa Canada 2012 Inc.

ATARAX (hydroxyzine) is an antihistamine that can increase the risk of QT prolongation (QTP) and torsade de pointes (TdP) which may lead to dizziness, palpitations, syncope, seizures, and sudden cardiac death.

Health Canada Health Product Risk Communication

Advisory
June 01, 2016

Unauthorized product, Animal Test, may pose serious risk to health

As a follow-up to a previous advisory, Health Canada is reminding Canadians about the serious risks posed by the unauthorized product "Animal Test,"after identifying additional retailers and a distributor selling the product. This product may pose a serious risk to the health of Canadians. The product is marketed as a dietary supplement and is labelled to contain yohimbine, a prescription drug ingredient.

Health Canada Advisory

Information Update
June 14, 2016

Health Canada clarifies position on W-18

The purpose of this Information Update is to clarify Health Canada's position on W-18, a potentially harmful substance that Health Canada has taken action to control under the Controlled Drugs and Substances Act (CDSA).

Health Canada Information Update

Information Update
June 10, 2016

Operation Pangea highlights the dangers of buying health products online

The results of this year’s Operation Pangea, a global effort to disrupt the online sale of counterfeit and unlicensed pharmaceutical products and medical devices. are a reminder that buying health products online may be a health risk.

Health Canada Information Update

Foreign Product Alert
June 15, 2016

Health Canada is advising Canadians not to use these foreign health products as they may pose a health risk. These products have been found by regulators in other countries to contain undeclared drug ingredients, toxic substances or high levels of heavy metals, which may pose serious health risks. Prescription drugs should only be taken under the supervision of a health care practitioner.

These products are not authorized for sale in Canada and have not been found on the Canadian market, but they may have been brought into the country by travellers or purchased over the Internet.

[> More]